spacer
home > epc > autumn 2003 > patient diaries: a possible source of data inconsistency?
PUBLICATIONS
European Pharmaceutical Contractor

Patient Diaries: A Possible Source of Data Inconsistency?

Patient diaries constitute one of the most relevant sources of direct information in clinical research. They contain information provided directly by the most important participant in the clinical trial: the patient. This fact makes the diaries a key element when retrieving and analysing data, but also means that the quality and relevance of these data differs considerably from those recorded in the investigators' standard CRF.

When using patient diaries, it is the patient who fills out the diary forms with the information they consider to be accurate. Therefore, this information cannot be evaluated with the same confidence level as those provided by clinical research or health care professionals.

One of the most relevant problems raised from the use of patient diaries in clinical studies is the fact that inconsistencies are sometimes found between the data introduced in the diaries by the patients and those entered in the CRF by the investigator or the study co-ordinator. This problem is even more serious when patient diaries are used in the scope of multicentre, multinational and multilingual studies, when an additional possible bias can be introduced by the use of the various translated versions of the diaries.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Sebastián Pacios Merino, Vice President of Operations, Countries Group, PRA International

Sebastián Pacios Merino is Vice President of Operations, Countries Group at PRA International. Beginning his career as a GP in the Spanish national health service, Sebasti‡n has since moved into clinical research. His roles have included Medical Translator/Advisor for SANED, EDICOMPLET, Project Manager at ITEM-PHARMA and Clinical Research Manager at Verum ITEM-PHARMA/Phoenix International Espa–a, where he later became Director. He has experience in a broad range of therapeutic areas including CNS neurology, gastroenterology, dermatology, cardiology and infectious diseases such as HIV. Sebastián has a degree in Medicine from the Facultad de Medicina, Universidad Aut—noma de Madrid, Spain.

spacer
Sebastián Pacios Merino
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Health Appoints Ian Jennings as Chief Commercial Officer

PHILADELPHIA, PA – March 4, 2020: Signant Health is proud to announce the appointment of Ian Jennings as Chief Commercial Officer to help support the next phase of Signant Health’s growth as a leading advocate of patient focused technology solutions.
More info >>

White Papers

Case Study: Getting the Client’s Trust - Oncology Program

Cmed Clinical Services

Five years ago, a biopharmaceutical company chose Cmed to conduct a phase II oncology study. Cmed’s performance of the study and the good relationship established with the Client led Cmed to be awarded a second oncology trial which a couple of years ago was followed by a third, fourth and fifth.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement